Victory Capital Management Inc Axogen, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$7.35 - $10.81 $417,854 - $614,559	-56,851 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$8.38 - $17.34 $38,950 - $80,596	-4,648 Reduced 7.56%	56,851 $591,000
Q4 2019 Feb 06, 2020	BUY	$11.18 - $18.6 $50,880 - $84,648	4,551 Added 7.99%	61,499 $1.1 Million
Q4 2019 Feb 04, 2020	SELL	$11.18 - $18.6 $31,918 - $53,103	-2,855 Reduced 4.77%	56,948 $704,000
Q3 2019 Nov 12, 2019	BUY	$12.09 - $20.46 $706,454 - $1.2 Million	58,433 Added 4265.18%	59,803 $746,000
Q4 2018 Feb 05, 2019	SELL	$17.09 - $38.25 $4,460 - $9,983	-261 Reduced 16.0%	1,370 $28,000
Q3 2018 Nov 01, 2018	BUY	$34.05 - $55.9 $12,462 - $20,459	366 Added 28.93%	1,631 $60,000
Q1 2018 May 04, 2018	BUY	$24.4 - $40.25 $30,866 - $50,916	1,265 New	1,265 $46,000

180

36.4M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.